Early identification of golimumab-treated patients with higher likelihood of long-term retention

Early identification of golimumab-treated patients with higher likelihood of long-term retention

BackgroundThe early identification of patients’ profiles most likely to respond to and maintain long-term therapy with a biological drug can have clinical and cost-effectiveness implications.ObjectivesTo evaluate the utility of an innovative approach for early identification of patient profiles asso...

Full description

Bibliographic Details
Main Authors: Alicia García-Dorta, Enrique González-Dávila, Marta Sánchez-Jareño, Luis Cea-Calvo, Manuel Pombo-Suárez, Fernando Sánchez-Alonso, Isabel Castrejón, Federico Díaz-González
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
golimumab
treatment retention
rheumatoid arthritis
axial spondyloarthritis
psoriatic arthritis
biological therapy
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1359571/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1359571/full

Similar Items